Justine Lavoye News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Justine lavoye. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Justine Lavoye Today - Breaking & Trending Today
Cognoptix President & CEO, Susanne Wilke, PhD, MBA, to Present at Sachs 4th Annual Neuroscience Innovation Forum News provided by Share this article Share this article MARLBOROUGH, Mass., April 28, 2021 /PRNewswire/ Cognoptix, a leading medical device/diagnostics company dedicated to the early detection of Alzheimer s disease (AD), announced today that Dr. Susanne Wilke, the Company s President and Chief Executive Officer, will present a Spotlight Showcase of Cognoptix under the title Early-Stage Detection of Alzheimer s Disease – A Simple Eye Scan on Wednesday, April 28th at 12:10pm ET. Millions of people are living with Alzheimer s and many millions more are at risk of developing the disease. Damaging forms of beta-amyloid begin building up in the brain 20 years before people begin to show signs of memory loss and confusion. At this time, amyloid PET brain scans are the only way to test for these damaging protein deposits while they are costly and ti ....
Share this article Share this article MARLBOROUGH, Mass., Jan. 11, 2021 /PRNewswire/ Cognoptix, a privately-held, diagnostics company with a breakthrough technology for the early detection of Alzheimer s disease (AD), announces that the company will present at the 13 th Annual Biotech Showcase™ Digital Event, January 11-15, 2021. Dr. Susanne Wilke, Cognoptix President and CEO, will present an overview of the Cognoptix Sapphire II technology in a talk titled Sapphire II: A Breakthrough Technology For The Early-Stage Detection of Alzheimer s Disease. Dr. Wilke will discuss Cognoptix Sapphire II technology for early AD detection in the lens of the eye. β-amyloid (Aβ) is expressed in the brain where these neurotoxic peptides aggregate into amyloid plaque. Amyloid plaque is established by National Institute of Aging–Alzheimer Association (NIA-AA) criteria to be the earliest and mandatory hallmark pathology for AD. Extensive research has established that AD ....
MARLBOROUGH, Mass., Jan. 4, 2021 /PRNewswire/ Cognoptix, a leading diagnostics company dedicated to the early detection of Alzheimer s disease (AD), announces two appointments to its senior management team. Dr. Carl H. Sadowsky, MD will serve as the company s new Chief Medical Officer (CMO) and Mike Kaswan, MBA will be Cognoptix s Chief Financial Officer (CFO). Dr. Sadowsky is nationally renowned physician and researcher in AD and neurodegenerative diseases. He is a Clinical Professor of Neurology at Nova SE University and was the Founding Director of Research at the Palm Beach Neurology and Premiere Research Institute in West Palm Beach, Florida, a nationally recognized clinical research group focused on AD. Among his notable successes, Dr. Sadowsky has conducted over 300 Alzheimer s clinical trials, including the amyloid PET Amyvid trial and the IDEAS trial. He served on the scientific review board for Alzheimer s Drug Discovery Fo ....